Pharmaceutical Intermediates Market - By Size, Regional Overview, Share Analysis And Future Outlook 2023-2032

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Pharmaceutical Intermediates Global Market Report 2023 identifies rise in the prevalence of chronic diseases as the major driver for the Pharmaceutical Intermediates market's growth in the forecast period. Chronic diseases refer to a sickness or condition that typically lasts three months or longer and has the potential to worsen over time. The rise in chronic diseases is mostly driven by the aging population, lifestyle changes, rapid urbanization, and lack of preventive measures, where pharmaceutical intermediates play a crucial role in the development and production of medications used to manage chronic diseases.

The global pharmaceutical intermediates market size is expected to grow from $29.11 billion in 2022 to $31.33 billion in 2023 at a compound annual growth rate (CAGR) of 7.62%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The size of pharmaceutical intermediates market is expected to reach $40.15 billion in 2027 at a CAGR of 6.40%.

Download Free Sample Of Pharmaceutical Intermediates Market Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=11948&type=smp

Major competitors in the Pharmaceutical Intermediates market are BASF SE, Sanofi SA, Thermo Fisher Scientific Inc, Meck KGaA, Dishman Carbogen Amcis Ltd, Evonik Industries AG, Arkema Inc.

A key trend in the Pharmaceutical Intermediates market includes product innovation. Major market players are concentrating their efforts on creating innovative products to strengthen their position in the market. For instance, in December 2020, BASF Pharma Solutions, a Germany-based provider of excipients and innovative solutions for the pharmaceutical industry, launched their new excipient called Soluplus. The U.S. Food and Drug Administration (FDA) accepted Soluplus into the FDA's Pilot Program for the Review of Innovation and Modernization of Excipients (PRIME). The FDA's evaluation aims to assess the excipient's safety, effectiveness, and potential impact on drug development and manufacturing.

Read More On The Global Pharmaceutical Intermediates Market Report Here:
https://www.thebusinessresearchcompany.com/report/pharmaceutical-intermediates-global-market-report

The Pharmaceutical Intermediates market is segmented -

• By Product: Chemical Intermediate, Bulk Drug Intermediate, Other Products
• By Category: Branded Drug Intermediate, Generic Drug Intermediate
• By Application: Analgesics, Anti-Infective Drugs, Cardiovascular Drugs, Oral Antidiabetic Drugs, Antimicrobial Drugs, Other Applications
• By End-User: Biotech And Pharma Companies, Research Institutions, Other End-Users
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Pharmaceutical Intermediates market.

The Business Research Company's "Global Pharmaceutical Intermediates Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Pharmaceutical Intermediates Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11948

The Table Of Content For The Pharmaceutical Intermediates Market Include:

1. Executive Summary
2. Pharmaceutical Intermediates Market Characteristics
3. Pharmaceutical Intermediates Market Trends And Strategies
4. Pharmaceutical Intermediates Market - Macro Economic Scenario
5. Global Pharmaceutical Intermediates Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
…………………………………………..
32. Global Pharmaceutical Intermediates Market Competitive Benchmarking
33. Global Pharmaceutical Intermediates Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Pharmaceutical Intermediates Market
35. Pharmaceutical Intermediates Market Future Outlook and Potential Analysis
36. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.